DUBLIN–(BUSINESS WIRE)–The “CD137 Antibodies Clinical Trials & Market Opportunity Insight” report has been added to ResearchAndMarkets.com’s offering. The market potential for effective CD137 antibodies is significant, considering the wide range of applications of CD137-targeted treatments in cancer. New and efficient treatment modalities are highly sought after, as the global market for cancer immunotherapy is expected to grow to many billions of dollars in the next several years. A size
发布者：Dr.Durant，转转请注明出处：https://robotalks.cn/cd137-antibodies-market-research-2024-2027-400-million-opportunity-in-initial-24-months-of-launch-80-drugs-in-clinical-trials-7-drugs-in-phase-ii-researchandmarkets-com/
